Peripheral endocannabinoid system activity in patients treated with sibutramine.
about
Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis.Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise.Effect of whey protein supplementation on levels of endocannabinoids and some of metabolic risk factors in obese women on a weight-loss diet: a study protocol for a randomized controlled trial.Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.
P2860
Peripheral endocannabinoid system activity in patients treated with sibutramine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Peripheral endocannabinoid system activity in patients treated with sibutramine.
@en
type
label
Peripheral endocannabinoid system activity in patients treated with sibutramine.
@en
prefLabel
Peripheral endocannabinoid system activity in patients treated with sibutramine.
@en
P2093
P2860
P50
P356
P1433
P1476
Peripheral endocannabinoid system activity in patients treated with sibutramine.
@en
P2093
Jens Jordan
Judith Harvey-White
Jürgen Janke
Kerstin Gorzelniak
Stefan Engeli
Sándor Bátkai
P2860
P304
P356
10.1038/OBY.2008.47
P577
2008-03-06T00:00:00Z